Clinical Trial Update: Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of AVANZ Phleum pratense for grass pollen-induced allergic rhinoconjunctivitis in a controlled …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Grass Pollen-induced Allergic Rhinoconjunctivitis

Drugs mentioned

• Avanz Phleum Pratense (Phleum pratense pollen allergen extract)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Grass Pollen Induced Allergic Rhinoconjunctivitis | Phase 2 | Status: COMPLETED